IRIS Accounts Production v23.2.0.158 11544190 Board of Directors 1.4.22 31.3.23 31.3.23 false true false false true false Ordinary 1.00000 Preference 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure115441902022-03-31115441902023-03-31115441902022-04-012023-03-31115441902021-03-31115441902021-04-012022-03-31115441902022-03-3111544190ns16:EnglandWales2022-04-012023-03-3111544190ns15:PoundSterling2022-04-012023-03-3111544190ns11:Director12022-04-012023-03-3111544190ns11:PrivateLimitedCompanyLtd2022-04-012023-03-3111544190ns11:SmallEntities2022-04-012023-03-3111544190ns11:AuditExempt-NoAccountantsReport2022-04-012023-03-3111544190ns11:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3111544190ns11:SmallCompaniesRegimeForAccounts2022-04-012023-03-3111544190ns11:FullAccounts2022-04-012023-03-3111544190ns11:OrdinaryShareClass12022-04-012023-03-3111544190ns11:OrdinaryShareClass22022-04-012023-03-3111544190ns11:Director22022-04-012023-03-3111544190ns11:RegisteredOffice2022-04-012023-03-3111544190ns6:CurrentFinancialInstruments2023-03-3111544190ns6:CurrentFinancialInstruments2022-03-3111544190ns6:Non-currentFinancialInstruments2023-03-3111544190ns6:Non-currentFinancialInstruments2022-03-3111544190ns6:ShareCapital2023-03-3111544190ns6:ShareCapital2022-03-3111544190ns6:RetainedEarningsAccumulatedLosses2023-03-3111544190ns6:RetainedEarningsAccumulatedLosses2022-03-3111544190ns6:PlantMachinery2022-04-012023-03-3111544190ns6:PlantMachinery2022-03-3111544190ns6:PlantMachinery2023-03-3111544190ns6:PlantMachinery2022-03-3111544190ns6:WithinOneYearns6:CurrentFinancialInstruments2023-03-3111544190ns6:WithinOneYearns6:CurrentFinancialInstruments2022-03-3111544190ns11:OrdinaryShareClass12023-03-3111544190ns11:OrdinaryShareClass22023-03-31
REGISTERED NUMBER: 11544190 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31ST MARCH 2023

FOR

CHARTERHOUSE MEDICAL UK LIMITED

CHARTERHOUSE MEDICAL UK LIMITED (REGISTERED NUMBER: 11544190)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


CHARTERHOUSE MEDICAL UK LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31ST MARCH 2023







DIRECTORS: Mr L C Fernandes
Ms S M Hewitson





REGISTERED OFFICE: 1 Doughty Street
London
WC1N 2PH





REGISTERED NUMBER: 11544190 (England and Wales)






CHARTERHOUSE MEDICAL UK LIMITED (REGISTERED NUMBER: 11544190)

BALANCE SHEET
31ST MARCH 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 30,040 18,746

CURRENT ASSETS
Debtors 5 843,439 1,048,725
Prepayments and accrued income 351,730 -
Cash at bank 5,753 7,688
1,200,922 1,056,413
CREDITORS
Amounts falling due within one year 6 960,754 733,579
NET CURRENT ASSETS 240,168 322,834
TOTAL ASSETS LESS CURRENT
LIABILITIES

270,208

341,580

CREDITORS
Amounts falling due after more than one year 7 11,685 142,513
NET ASSETS 258,523 199,067

CAPITAL AND RESERVES
Called up share capital 8 500,100 500,100
Retained earnings (241,577 ) (301,033 )
SHAREHOLDERS' FUNDS 258,523 199,067

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

CHARTERHOUSE MEDICAL UK LIMITED (REGISTERED NUMBER: 11544190)

BALANCE SHEET - continued
31ST MARCH 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 5th October 2023 and were signed on its behalf by:





Mr L C Fernandes - Director


CHARTERHOUSE MEDICAL UK LIMITED (REGISTERED NUMBER: 11544190)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MARCH 2023


1. STATUTORY INFORMATION

Charterhouse Medical UK Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

CHARTERHOUSE MEDICAL UK LIMITED (REGISTERED NUMBER: 11544190)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MARCH 2023


2. ACCOUNTING POLICIES - continued

Government grants
Government grants are recognised when it is reasonable to expect that the grants will be received and that all related conditions will be met, usually on submission of a valid claim for payment.

Government grants in respect of capital expenditure are credited to a deferred income account and are released to profit over the expected useful lives of the relevant assets by equal annual instalments.

Grants of a revenue nature are credited to income so as to match them with the expenditure to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 22 (2022 - 15 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1st April 2022 51,516
Additions 26,480
At 31st March 2023 77,996
DEPRECIATION
At 1st April 2022 32,770
Charge for year 15,186
At 31st March 2023 47,956
NET BOOK VALUE
At 31st March 2023 30,040
At 31st March 2022 18,746

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 778,334 839,632
Other debtors 65,105 209,093
843,439 1,048,725

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Bank loans and overdrafts 200,934 253,815
Trade creditors 178,863 15,690
Taxation and social security 195,589 204,443
Other creditors 385,368 259,631
960,754 733,579

CHARTERHOUSE MEDICAL UK LIMITED (REGISTERED NUMBER: 11544190)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MARCH 2023


7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2023 2022
£    £   
Other creditors 11,685 142,513

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
100 Ordinary £100 100 100
500,000 Preference £1 500,000 500,000
500,100 500,100

9. OTHER FINANCIAL COMMITMENTS

As at the year end, total financial commitments amounted to £230,076(2022: £50,137).

10. RELATED PARTY DISCLOSURES

At the year end, the company owed £11,685 (2022: £142,513) to a shareholder for services provided at arms length and on commercial terms.

11. ULTIMATE CONTROLLING PARTY

The controlling party is Mr L C Fernandes.